Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
DEVELOPMENT OF TBI ASSAYS BY ABBOTT LABORATORIES, INC., POINT OF CARE DIVISION (ABBOTT), USING BANYAN BIOMARKERS UCH-L1… is a federal NONE award for W4pz Usa Med Rsch Acquis Act held by Abbott Laboratories Inc. Estimated value $37.6M ($7.5M obligated). Current period of performance ends Sep 30, 2027. Last award drew 1 bidder. Place of performance: NORTH CHICAGO, IL. Related solicitation W81XWH19R0074.
DEVELOPMENT OF TBI ASSAYS BY ABBOTT LABORATORIES, INC., POINT OF CARE DIVISION (ABBOTT), USING BANYAN BIOMARKERS UCH-L1 AND GFAP FOR USE ON THE ABBOTT I-STAT DEVICE.
Recompete timing
PublicCurrent PoP ends Sep 30, 2027 (388 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordAbbott Laboratories Inc — $290.5M obligated across 2,286 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81XWH19C0071?
W81XWH19C0071 (ABBOTT ABBOTT development TBI ASSAYS BY) is a W4pz Usa Med Rsch Acquis Act award with an estimated value of $37.6M, currently held by Abbott Laboratories Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81XWH-19-C-0071?
W81XWH-19-C-0071 is the dashed form of PIID W81XWH19C0071 (ABBOTT ABBOTT development TBI ASSAYS BY), held by Abbott Laboratories Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81XWH19C0071?
W4pz Usa Med Rsch Acquis Act awarded W81XWH19C0071 to Abbott Laboratories Inc.
Who is the incumbent on W81XWH19C0071?
Abbott Laboratories Inc is the incumbent with $290.5M across 2286 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.
When does Abbott Laboratories Inc’s W81XWH19C0071 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on W81XWH19C0071 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.